| ID | 1503 | |
| PMID | 15603887 | |
| Year | 2005 | |
| Sequence | SKYALVDASLKMADP NRFRGKDLPVLDQL | |
| Name | gD 1-29 (group 1) | |
| Length | 29 | |
| N-Terminal Modification | Free | |
| C-Terminal Modification | Free | |
| Linear/ Cyclic | Linear | |
| Chirality | L | |
| Chemical Modification | None | |
| Origin of Peptide | T-cell epitope peptide identified from HSV1-gD | |
| Nature of Peptide/Cargo | not mentioned | |
| Mechanism | T-cell epitope peptide identified from HSV1-gD | |
| Cargo Sequence/Structure | None | |
| Name of cargo | Not applicable | |
| Assay | ELISA, Antibody assay, Peptide specific T-cell assays | |
| Enhancer | PBS (pH 7.3). | |
| Properties of enhancer | Not mentioned | |
| Concentration | 25ul | |
| Incubation time | 21 days | |
| Tissue permeability (value with units) | Failed to induce significant IgA titers (p > 1). | |
| Tissue Sample | eye | |
| Ex vivo/In vivo/In vitro | in vivo | |
| STRUCTURE |
| |
| SMILES | N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N[C@H](C(=O)N[C@H]([C@H](O)N[C@H](C(=O)N[C@H]([C@@H] 1OO[C@@H]([C@@H](NC(=O)CNC(=O)[C@@H](N[C@@H]2 [C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]3N(C(=O) [C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O) [C@@H](NC(=O)[C@@H](N1)CO)CC(C)C)CCCCN)CCSC)C) CC(=O)O)CCC3)CC(=O)N)CCCNC(=N)N)Cc1ccccc1O2) CCCNC(=N)N)CCCCN)N[C@H](C(=O)N[C@H](C(=O)N1 [C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H] (C(=O)N[C@H](C(=O)N[C@H](C=O)CC(C)C)CCC(=O)N)CC(=O)O) CC(C)C)C(C)C)CCC1)CC(C)C)CC(=O)O)C)CC(=O)O) C(C)C)CC(C)C)C)Cc1ccc(cc1)O)CCCCN)CO | |